Moderna (MRNA) IV into BARDA additional $472M commitment

Moderna (NASDAQ: MRNA) Moderna (NASDAQ: MRNA) July weekly call option implied volatility is at 97, August is at 102; compared to its 52-week range of 51 to 172 into Biomedical Advanced Research and Development Authority, or BARDA, making an additional commitment of up to $472M to support late stage clinical development including the expanded Phase 3 study of the company's mRNA vaccine candidate against COVID-19.

You May Also Be Interested In

• Apple (AAPL) call put ratio 1.1 calls 1 put into hosting a special event
• Sandisk (SNDK) call put ratio 1.6 calls to 1 put as share price up 8.2%
• FICO (FICO) call put ratio 1 call to 1.1 puts as share price down 17%